Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/10/2025

Nephrotic Syndrome Causes and Management

Primary Causes of Nephrotic Syndrome

  • Nephrotic syndrome is primarily caused by three major histologic variants: minimal change disease, focal segmental glomerulosclerosis (FSGS), and membranous nephropathy, with the relative frequency varying by age and ethnicity 1
  • Immunoglobulin and complement-mediated glomerular diseases with an MPGN pattern can also cause nephrotic syndrome 1

Secondary Causes of Nephrotic Syndrome

  • Various infectious agents can trigger infection-related glomerulonephritis leading to nephrotic syndrome 1
  • Solid tumors can be associated with paraneoplastic glomerular disease 1
  • Cancer therapies, including targeted agents and immunotherapies, may cause podocytopathies 1
  • Anti-angiogenesis drugs are associated with proteinuria and lesions such as minimal change disease/FSGS 1
  • Immune checkpoint inhibitors can cause nephrotic syndrome 1

Pathophysiology Considerations

  • Primary T-cell disorders may be responsible for minimal change disease and FSGS, with a proposed T-cell-driven circulating factor that interferes with glomerular permeability to albumin 1
  • Membranous nephropathy has been definitively proven to be an autoimmune disease 1
  • The 2021 KDIGO guidelines propose a classification of FSGS to help differentiate between primary FSGS (which may respond to immunosuppression) and secondary forms (which typically don't) 2

Clinical Implications and Management Approach

  • In primary FSGS with nephrotic syndrome, immunosuppression has been shown to improve proteinuria and slow progression to ESRD 3
  • Patients with proteinuria >3.8 g/day have a 35% risk of end-stage renal disease within 2 years if left untreated 1
  • Complications of nephrotic syndrome include hyperlipidemia, venous thromboembolism, increased risk of infection, and accelerated coronary heart disease 1